LBI-HTA - Publications - Search - Horizon Scanning in Oncology: Results of the 27th Prioritisation – 2nd quarter 2016

Grössmann, N. and Wild, C. (2016): Horizon Scanning in Oncology: Results of the 27th Prioritisation – 2nd quarter 2016 . HSO: 27th Prioritisation.

[img]PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
535Kb
Abstract

For the 27th prioritisation (June 2016), 12 drugs were filtered out of 282 identified and were sent to prioritisation. Of these, 5 drugs were ranked as 'highly relevant' by the expert panel, 7 as 'relevant' and none as 'not relevant'. For 'highly relevant' drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.

Item Type:DSD: Horizon Scanning in Oncology
Subjects:WB Practice of medicine > WB 300-962 Therapeutics
QZ Pathology > QZ 200-380 Neoplasms.Cysts
QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
Language:English
Series Name:HSO: 27th Prioritisation
Deposited on:05 Aug 2016 19:52
Last Modified:19 Oct 2016 14:23

Repository Staff Only: item control page